Company intelligence / Profile preview
BioXcellerator
Phoenix* / Scottsdale*, AZ, USAbioxcellerator.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
BioXcellerator claims thousands of successful patient outcomes using high-potency mesenchymal stem cells for a wide range of indications including orthopedic injuries, autoimmune disorders, degenerative diseases, diabetes, TBI/CTE and cosmetic applications. The company markets its therapies as safe with a strong reputation among athletes and celebrities but lacks robust published clinical data supporting efficacy or long-term safety.
- Therapeutic areas
- RheumatologyEndocrinologyImmunologyDermatologyNeurology
- Modalities
- Mesenchymal stem cells (MSCs) from Wharton’s jelly (umbilical cord)ExosomesAllogenic cell therapy"Signature Cells" and "Golden Cells" proprietary formulations
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharmaceutical or biotech partnerships disclosed. Focus appears to be direct-to-patient services via medical tourism model.
Beyond the preview
Go deeper on BioXcellerator.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioXcellerator.